Acute and subacute toxic effects of CUMYL-4CN-BINACA on male albino rats
- PMID: 38102417
- DOI: 10.1007/s11419-023-00676-8
Acute and subacute toxic effects of CUMYL-4CN-BINACA on male albino rats
Abstract
Purpose: There is very little information about the toxicological and pathological effects of synthetic cannabinoids, which have cannabis-like properties. This study was carried out to histopathologically, hematologically, and biochemically determine the toxic effects of acute and subacute exposure to a novel synthetic cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide in internal organs of adult male rats.
Methods: The cannabinoid was injected intraperitoneally at three doses (0.5, 1.0, and 2.0 mg/kg, body weight). The cannabinoid was administered to acute groups for 2 days and to subacute groups for 14 days. Observations were made for 14 days and various changes such as mortality, injury, and illness were recorded daily. Hematological and biochemical changes were evaluated and histopathological analyses in lung, liver, and kidney tissues were also performed.
Results: No mortality was observed. It was observed that there were fluctuations in hematological and serum biochemical parameters. Among the oxidative stress parameters, significant decreases in superoxide dismutase, catalase levels and significant increases in lipid peroxidation levels were determined. Serious pathological changes such as necrosis, vacuolation, congestion, and fibrosis were observed in the internal organs in a dose-dependent and time-dependent manner. It was also found that the synthetic cannabinoid triggered apoptosis in the organs. The results demonstrated that the most affected organ by the cannabinoid was the kidney.
Conclusion: This study showed for the first time that CUMYL-4CN-BINACA adversely affects healthy male albino rats. It can be estimated that the abuse of the cannabinoid may harm human health in the same way.
Keywords: Apoptosis; CUMYL-4CN-BINACA; Hematological profile; Internal organ histology; Preclinical toxicity.
© 2023. The Author(s), under exclusive licence to Japanese Association of Forensic Toxicology.
Similar articles
-
A study on the possible neurotoxic effects of CUMYL-4CN-BINACA in Sprague Dawley rats.Leg Med (Tokyo). 2024 Mar;67:102389. doi: 10.1016/j.legalmed.2023.102389. Epub 2023 Dec 29. Leg Med (Tokyo). 2024. PMID: 38185093
-
Synthetic cannabinoid CUMYL-4CN-BINACA induces oxidative stress, ER stress, and apoptosis in brain and testicular tissues of male albino rats.Food Chem Toxicol. 2025 Oct;204:115617. doi: 10.1016/j.fct.2025.115617. Epub 2025 Jul 4. Food Chem Toxicol. 2025. PMID: 40618914
-
Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.Drug Test Anal. 2018 Mar;10(3):449-459. doi: 10.1002/dta.2248. Epub 2017 Aug 24. Drug Test Anal. 2018. PMID: 28691766
-
Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples.J Anal Toxicol. 2017 Nov 1;41(9):720-728. doi: 10.1093/jat/bkx061. J Anal Toxicol. 2017. PMID: 28977413
-
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist.Front Pharmacol. 2019 May 29;10:595. doi: 10.3389/fphar.2019.00595. eCollection 2019. Front Pharmacol. 2019. PMID: 31191320 Free PMC article.
References
-
- Dignam G, Bigham C (2017) Novel psychoactive substances: a practical approach to dealing with toxicity from legal highs. BJA Education 17(5):172–177. https://doi.org/10.1093/bjaed/mkw068 - DOI
-
- The European Monitoring Centre for Drugs and Drug Addiction (2022) Trends and Developments. Available online: https://www.emcdda.europa.eu/publications/edr/trends-developments/2022_en (Accessed on 12 May 2023).
-
- Cooper ZD (2016) Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep 18:52. https://doi.org/10.1007/s11920-016-0694-1 - DOI - PubMed - PMC
-
- Hermanns-Clausen M, Müller D, Kithinji J, Angerer V, Franz F, Eyer F, Neurath H, Liebetrau G, Auwärter V (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicol 56(6):404–411. https://doi.org/10.1080/15563650.2017.1393082 - DOI
-
- Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction (Abingdon, England) 108(3):534–544. https://doi.org/10.1111/j.1360-0443.2012.04078.x - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources